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Abstract In bone development and regeneration, angiogenesis
and bone/cartilage resorption are essential processes and are
closely associated with each other, suggesting a common
mediator for these two biological events. To address this
interrelationship, we examined the effect of vascular endothelial
growth factor (VEGF), the most critical growth factor for
angiogenesis, on osteoclastic bone-resorbing activity in a culture
of highly purified rabbit mature osteoclasts. VEGF caused a
dose- and time-dependent increase in the area of bone resorption
pits excavated by the isolated osteoclasts, partially by enhancing
the survival of the cells. Two distinct VEGF receptors, KDR/Flk-
1 and Flt-1, were detectable in osteoclasts at the gene and protein
levels, and VEGF induced tyrosine phosphorylation of proteins in
osteoclasts. Thus, osteoclastic function and angiogenesis are up-
regulated by a common mediator such as VEGF.
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1. Introduction
Angiogenesis is required for the development, remodeling
and repairing of most tissue including bone. In skeleton, the
appearance of bone/cartilage-resorbing cells such as osteo-
clasts and chondroclasts coincides with blood vessel invasion,
and the formation of new capillaries and the resorption of
mineralized matrices are essential events for bone morphogen-
esis and growth [1]. This intimate interrelationship between
the bone/cartilage resorption and the angiogenesis also occurs
in pathological bone disorders including bone metastasis and
rheumatoid arthritis [2,3]. Thus, the simultaneous appearance
of the bone/cartilage-resorbing and the invasion by blood
vessels suggests that there may be a common modulator
that regulates both angiogenesis and bone/cartilage resorp-
tion.
Vascular endothelial growth factor (VEGF) is the most im-
portant essential mediator of angiogenesis [4]. Although
VEGF is secreted by many cell types, osteoblasts and chon-
drocytes have been reported to produce this cytokine in the
skeleton [5,6]. Besides the stimulation of angiogenesis, VEGF
has also been demonstrated to be involved in early hemato-
poietic development and chemotaxis of monocytes [7,8]. A
recent immunohistological study revealed the expression of
VEGF receptors on chondroclasts as well as on endothelial
cells [6]. In addition, it has most recently been demonstrated
that VEGF induced osteoclastogenesis with a combination of
receptor activator of NF-UB ligand (RANKL) [9]. These ¢nd-
ings suggest that VEGF may regulate osteoclast di¡erentia-
tion as well as angiogenesis. However, there is no information
about the direct action of VEGF on the function of fully
di¡erentiated osteoclasts in vitro.
In this study, using a population of functional osteoclasts of
extremely high purity (more than 95%) from rabbit bones [10],
we examined if VEGF directly acts on osteoclast function and
if VEGF receptors are expressed in mature osteoclasts. Here
we report our ¢ndings indicating that VEGF directly enhances
the osteoclastic bone resorption probably through KDR/Flk-1
and/or Flt-1 expressed in mature osteoclasts.
2. Materials and methods
2.1. Isolation of mature osteoclasts and pit assay
Puri¢ed mature osteoclasts were prepared using 10-day-old rabbits
as described previously [10]. Brie£y, long bones from 10-day-old rab-
bits were minced with scissors and agitated with a vortex mixer. An
aliquot of unfractionated bone cells was seeded onto 0.24% collagen
gel (Nitta Gelatin, Tokyo) coated on 100-mm tissue culture dishes and
incubated. Two hours later, the non-adherent cells were washed o¡
and the remaining osteoclasts were then removed from the gels with
0.1% collagenase solution (Wako Pure Chemicals Co.). By staining
with tartrate resistant acid phosphatase (TRAP), we ascertained that
more than 95% of isolated cells were multinucleate osteoclasts. Iso-
lated osteoclasts (200 cells/well) were cultured on a dentine slice
placed in each well of 96-well plates containing 0.1 ml of K-MEM/
5% fetal bovine serum (FBS). After a 2-h incubation, the medium was
then replaced with the fresh medium with or without recombinant
human VEGF (165-amino acid form, Genzyme/Techne, Cambridge,
MA, USA). After culture, the cells were scraped o¡ the dentine slices,
and the slices were stained with acid hematoxylin [11]. The stained pit
areas were determined under a microscope at U100 magni¢cation by
counting the number of mesh squares (100U100 Wm) covering the pit
to evaluate possible osteoclastic bone resorption. In the case of TRAP
staining, after ¢xation, the osteoclasts were stained for TRAP activity
with a leukocyte acid phosphatase kit (Sigma Chemical Co., St. Louis,
MO, USA), and the number of adherent TRAP-positive osteoclasts
was counted.
For Western blot analysis and reverse transcription-polymerase
chain reaction (RT-PCR), we puri¢ed rabbit osteoclasts on plastic
dishes by the method of Tezuka et al. [12]. Brie£y, the above unfrac-
tionated bone cells were plated into 100-mm tissue culture dishes, and
after an overnight culture, the non-adherent cells were removed by
several washes with phosphate-bu¡ered saline (PBS). We used the
remaining adherent cells for immunocytochemical detection of
VEGF receptors (KDR/Flk-1 and Flt-1). The adherent cells were in-
cubated in PBS containing 0.001% pronase E and 0.02% EDTA for
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10 min at room temperature. By this incubation, cells other than
osteoclasts became detached from dishes and were washed o¡. The
purity of the remaining osteoclastic multinucleate cells on the plastic
dishes was also more than 95%.
2.2. Normal human umbilical vein endothelial cell (HUVEC) cultures
HUVECs, purchased from Bio Whittaker (Walkersville, MD,
USA), were cultured in the manufacturer’s recommended medium
(EBM-2) supplemented with EGM-2 SingleQuots (2% FBS, 0.4 Wg/
ml hydrocortisone, 4 Wg/ml recombinant human bFGF, 1 Wg/ml
VEGF, 1 Wg/ml R3-IGF-1, 1 Wg/ml ascorbic acid, 1 Wg/ml recombi-
nant human EGF, 1 Wg/ml GA-1000, 1 Wg/ml heparin) at 37‡C in a
5% CO2 incubator. We used these cells at early passages (2^3) for RT-
PCR, immunocytochemistry and immunoblot analysis as a positive
control.
2.3. Assay for tyrosine phosphorylation of cellular proteins
The isolated osteoclasts on plastic dishes were cultured in K-MEM
supplemented with 5% FBS for 3 h. Then, the osteoclasts were treated
with various concentrations VEGF for various periods. The cells were
quickly washed with ice-cold PBS containing 5 mM EDTA and 1 mM
Na3VO4, and lysed with a lysis bu¡er consisting of 20 mM Tris^HCl
(pH 7.4), 150 mM NaCl, 10 mM NaH2PO4, 5 mM EDTA, 10 mM
NaF, 1% Triton X-100, 10% glycerol, 1 mM Na3VO4, 1 mM amino-
ethyl-benzenesulfonyl £uoride (ABSF), 10 Wg/ml aprotinin and 10 Wg/
ml leupeptin. The protein concentration in the cell lysate was meas-
ured with a bicinchoninic acid protein assay kit (Pierce Chemical Co.,
Rockford, IL, USA). Each cell lysate containing equal amounts of
protein was electrophoresed through 8% SDS^PAGE and transferred
onto a polyvinylidene di£uoride (PVDF) membrane. After blockage
with 5% bovine serum albumin, the membrane was incubated with
0.5 Wg/ml of anti-phosphotyrosine antibody (Upstate Biotechnology,
Lake Placid, NY, USA) and subsequently with 0.2 Wg/ml of peroxi-
dase-conjugated anti-mouse IgG antibody. Phosphotyrosine-contain-
ing proteins were visualized with the use of Western blot chemilumi-
nescence reagents (Dupont New England Nuclear Products, Boston,
MA, USA) following the manufacturer’s instructions.
2.4. RT-PCR
Total RNA was extracted from rabbit osteoclasts prepared as men-
tioned above, from rabbit aorta freshly obtained from a 7-day-old
rabbit, and from HUVECs by acid guanidium thiocyanate^phenol^
chloroform extraction with TRIZOL0 reagent (Gibco BRL, Gaithers-
burg, MD, USA). The ¢rst-strand cDNA was synthesized from 1 Wg
of total RNA using a superscript II preampli¢cation system (Gibco
BRL). Primers were designed on the basis of the reported human Flt-
1 and KDR/Flk-1 sequences (GenBank databases: AF063657 and
AF063658, respectively). Sequences of the primers used for PCR
were as follows: Flt-1 forward, 5P-TATGATGCCAGCAAGTGGG-
A-3P ; Flt-1 reverse, 5P-TGCCAGCAGTCCAGCATGAT-3P ; KDR/
Flk-1 forward, 5P-CAAGTGGCTAAGGGCATGGA-3P ; KDR/Flk-
1 reverse, 5P-CAGCAGTCCAGCATGGTCTG-3P. Ampli¢cation
was carried out for 30 cycles (94‡C, 30 s; 58‡C, 30 s; 72‡C, 1 min
for each in a 50-Wl reaction solution containing 5 Wl of each cDNA,
1 WM of sense and antisense primers, 1.25 U of Taq DNA polymerase
(Qiagen GmbH, Hilden, Germany) and 0.2 mM of each dNTP. The
PCR products were analyzed by 1.5% agarose gel electrophoresis and
visualized by ethidium bromide staining. The ampli¢ed cDNAs for
KDR/Flt-1 and Flt-1 from rabbit osteoclasts were subcloned into the
pCR 3.1 vector (Invitrogen Corp., San Diego, CA, USA) according to
the manufacturer’s instructions. Each cDNA insert was sequenced by
the dideoxynucleotide chain termination method, using a BioDye Ter-
minator Cycle Sequencing kit and an ABI PRISM 310 Genetic Ana-
lyzer(PE Biosystems, Foster City, CA, USA).
2.5. Immunocytochemistry and immunoblot analysis for KDR/Flk-1
and Flt-1
Uunfractionated bone cells were ¢xed with ice-cold ¢xation solution
consisting of 25 mM sodium phosphate (pH 7.5), 45% acetone and 9%
formaldehyde for 3 min at 4‡C. After having been blocked with 5%
skim milk and 0.1% Triton X-100 in PBS, the ¢xed cells were immu-
noreacted with 1 Wg/ml of monoclonal mouse anti-KDR/Flk-1 IgG
(Santa Cruz Biotechnology, Inc., San Diego, CA, USA) or polyclonal
rabbit anti-Flt-1 IgG (Upstate Biotechnology, Lake Placid, NY,
USA), or non-immune mouse IgG or rabbit IgG, and subsequently
with 7.5 Wg/ml of biotin-conjugated anti-mouse and anti-rabbit IgGs,
respectively. The immunoreactive cells were visualized by the use of
avidin^biotin^peroxidase complex immunostaining reagents (Vector
Laboratories, Inc., Burlingame, CA, USA) following the manufactur-
er’s instructions.
In the case of Western blot analysis, the isolated osteoclasts on
plastic dishes and HUVECs were lysed by sonication in a lysis bu¡er
consisting of 10 mM Tris^HCl (pH 7.4), 250 mM sucrose, 1 mM
EDTA, 2 mM ABSF, 10 Wg/ml aprotinin, 10 Wg/ml leupeptin and
10 Wg/ml pepstatin. The cell lysates were then centrifuged at
30 000Ug for 30 min and the obtained pellets were dissolved in
Laemmli’s sample bu¡er. The samples were electrophoresed through
7.5% SDS^PAGE and transferred onto a PVDF membrane. After
blockage with 5% skim milk, the membrane was immunoreacted
with 1 Wg/ml of anti-KDR/Flk-1 and anti-Flt-1 antibodies, subse-
quently with peroxidase-conjugated anti-mouse IgG and anti-rabbit
IgG antibodies, respectively. The proteins immunoreactive with anti-
KDR/Flk-1 or anti-Flt-1 antibody were visualized with Western blot
chemiluminescence reagents as mentioned above.
3. Results
The osteoclastic bone resorption in response to VEGF
treatment was ¢rst determined in cultures of rabbit isolated
Fig. 1. Dose- and time-dependent e¡ect of VEGF on bone resorption by mature osteoclasts. Isolated mature osteoclasts (200 cells) were incu-
bated with various concentrations of VEGF for 24 h (A), or incubated without (open circle) or with VEGF (100 ng/ml, closed circle) for the
indicated times (B). Then, the areas of pits excavated by the isolated osteoclasts were measured. The numbers of TRAP-positive osteoclasts on
the dentine slices were counted, and the percentage to the number of initially seeded osteoclasts was indicated as survival rate. The experiments
were performed four times, and the values are means þ S.D. for ¢ve cultures in a representative experiment. *P6 0.01 vs. untreated cells.
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osteoclasts. When the isolated osteoclasts were incubated with
VEGF on dentine slices for 18 h, VEGF dose- and time-de-
pendently stimulated the bone resorption by these cells (Fig.
1). The pit area at 100 ng/ml was about 1.7-fold over the
control value. In addition, VEGF increased the survival rate
of the isolated osteoclasts on the dentine slices in the same
concentration range, suggesting that the stimulation of osteo-
clastic bone resorption is mediated in part by enhancing the
osteoclast survival.
Osteoclasts are a member of the hematopoietic cell family
[13,14], and various types of hematopoietic cells have been
demonstrated to express VEGF receptors, which receptors
play roles in regulating the proliferation, development, che-
motaxis and survival of hematopoietic cells [7,8,15]. Taken
together with the previous ¢ndings, the above results suggest
the presence of VEGF receptors in the osteoclasts. Therefore,
we examined the expression of receptors of VEGF in isolated
osteoclasts. As shown in Fig. 2, RT-PCR analysis demon-
strated that cDNAs for KDR/Flk-1 and Flt-1 were ampli¢ed
in the sample obtained from isolated osteoclasts as well as in
those samples from HUVECs and rabbit aorta, whereas the
ampli¢cation was not shown in any samples not subjected to
the reverse transcriptase reaction. The nucleotide sequences of
the ampli¢ed rabbit cDNAs revealed a high homology to
those of human and mouse KDR/Flk-1 (75.7% and 77.1%
identical, respectively) and Flt-1 (90.6% and 90.7% identical,
respectively).
To detect expression of VEGF receptors on osteoclasts at
the protein level, using anti-KDR/Flk-1 and anti-Flt-1 anti-
bodies, we performed immunocytochemical staining of un-
fractionated bone cells. As shown in Fig. 3, multinucleate
osteoclasts were stained with the anti-KDR/Flk-1 and anti-
Flt-1 antibodies, whereas other bone cells were not. In addi-
tion, the protein expression of KDR/Flk-1 and Flt-1 on os-
teoclasts was also con¢rmed by Western blotting analysis of a
cytoplasmic membrane fraction from isolated osteoclasts (Fig.
3E). We found two immunoreactive protein bands with mo-
lecular masses of 200 kDa and 230 kDa corresponding to
mature forms of glycosylated KDR/Flk-1 in the osteoclastic
membrane fraction. In addition, the immunoreactive Flt-1
with a molecular mass of 180 kDa was also detected.
KDR/Flk-1 and Flt-1 belong to the family of receptor ty-
rosine kinases [16^18], and the action of VEGF is mediated by
the activation of intracellular tyrosine kinase through the au-
tophosphorylation of its receptors. Thus, we ¢nally examined
the relationship between tyrosine phosphorylation and
VEGF-induced osteoclastic bone-resorbing activity. The addi-
tion of VEGF to the isolated osteoclasts induced the stimula-
Fig. 2. RT-PCR analysis for the expression of VEGF receptors in
mature osteoclasts. (A) Equal amounts of total RNA from endothe-
lial HUVEC cells, rabbit (Rab.) aorta and isolated rabbit osteoclasts
(Rab. OC) were reverse-transcribed (RT, +), or not (RT, 3), and
then the samples were ampli¢ed with Flt-1 or KDR/Flk-1 primers.
The PCR products for Flt-1 and KDR/Flk-1 were 971 bp and 398
bp, respectively.
Fig. 3. Expression of VEGF receptor proteins in mature osteoclasts.
Rabbit unfractionated bone cells were immunostained with poly-
clonal rabbit anti-Flt-1 IgG (A), monoclonal mouse anti-KDR/Flk-1
IgG (C) antibody, non-immune rabbit IgG (B) or non-immune
mouse IgG (D). Note that multinucleate osteoclasts (arrows) were
positively immunoreactive for two distinct receptors of VEGF. Bar
in each photograph indicates 100 Wm. (E) Western blotting analysis
for VEGF receptors expressed on mature osteoclasts. Membrane
proteins were extracted from HUVEC cells (lanes 1 and 3) and iso-
lated mature osteoclasts (lanes 2 and 4), and used for Western blot-
ting analysis of KDR/Flk-1 (lanes 1 and 2) and Flt-1 (lanes 3 and
4). Arrows indicate immunoreactive bands for KDR/Flk-1 and Flt-
1, respectively.
Fig. 4. Involvement of protein tyrosine phosphorylation in the stim-
ulatory e¡ect of VEGF on osteoclastic bone resorption. Isolated os-
teoclasts were stimulated with various concentrations of VEGF for
2 min (A, B). Proteins in cell lysates were electrophoresed and then
Western-blotted with anti-phosphotyrosine (A) and anti-c-src (B)
antibodies. A c-Src signal in each lane serves as quantitative internal
control.
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tion of tyrosine phosphorylation of numerous cellular proteins
in a short-term exposure (Fig. 4).
4. Discussion
Our ¢ndings presented here indicate that a potent angio-
genic factor, VEGF, stimulated the bone-resorbing activity of
isolated rabbit osteoclasts, at least in part by enhancing the
survival. This is the ¢rst report indicating the direct action of
VEGF on the function of mature osteoclasts. Because the
isolated osteoclasts expressed two isoforms of VEGF recep-
tors, the stimulatory e¡ect could have been mediated through
either VEGF receptor, or through both of them. So, it re-
mains to be elucidated which receptor, KDR/Flk-1 or Flt-1,
is important to mediate the stimulatory e¡ect of VEGF in
osteoclasts.
The method employed for isolation of rabbit mature osteo-
clasts in this study is based on the much stronger adherence of
osteoclasts than that of non-osteoclastic cells to a collagen gel,
such that osteoclast cultures can be deleted of stromal cells
[10]. The isolated rabbit mature osteoclasts are capable of
resorbing dentine even in the absence of bone-derived osteo-
blastic/stromal cells. Thereby, direct actions of osteotropic
hormones and local factors on mature osteoclasts in vitro
can be precisely estimated without the in£uence of non-osteo-
clastic cells [19^21], and the culture system of rabbit isolated
osteoclasts on dentine slices provides us more information in
regulating osteoclastic function.
Recently, Niida et al. [9] demonstrated by several histo-
chemical analyses in vivo that VEGF can support the osteo-
clast recruitment in osteopetrotic op/op mice lacking produc-
tion of functional M-CSF. In addition, the action may be
mediated by Flt-1, suggesting that VEGF can substitute for
M-CSF in osteoclastogenesis under some circumstances. Us-
ing the culture system eliminating any cells other than osteo-
clasts, we obviously demonstrated the direct action of VEGF
on mature osteoclasts to enhance their function and survival
in vitro. The action of VEGF is close to that of M-CSF that
enhances osteoclast survival [22]. Taken together, the data
indicate that VEGF is an important regulator of osteoclastic
bone resorption.
A recent study demonstrated that at the bone/cartilage
junction site in the growth plate, administration of a soluble
VEGF receptor chimeric protein (mFlt-1-Fc) into mice caused
a complete suppression of blood vessel invasion, concomitant
with impaired trabecular bone formation, expansion of the
hypertrophic chondrocyte zone, and a decrease in cartilage
resorption followed by a reduction of recruitment and/or
function of chondroclasts [6]. It is well established that hyp-
oxia is one of the principal stimuli for the expression of
VEGF [23]. Because hypertrophic chondrocytes are in an
avascular environment, these cells are a potential source of
this cytokine within the growth plate [6]. In that study, it
was also reported that chondroclasts and osteoblasts as well
as epithelial cells expressed KDR/Flk-1 and Flt-1 [10]. These
¢ndings suggest that VEGF-mediated capillary invasion plays
a central role in growth plate morphogenesis by acting in a
paracrine manner. In addition, VEGF is also produced by
osteoblasts in the skeleton [5], and the expression of VEGF
was up-regulated by certain osteotropic factors such as 1,25-
dihydroxyvitamin D3 and prostaglandin E2, both of which are
potent stimulators of bone resorption [24,25]. Thus, VEGF
produced by osteoblasts in response to these osteotropic fac-
tors may be involved in the stimulation of osteoclastic bone
resorption. Finally, these results presented here provide a new
insight into the multifunctional roles played by VEGF in the
relationship between bone/cartilage resorption and angiogen-
esis.
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